Variants alleles in TELO2 rs4786772 (ORAG=1.54, 95%CI 1.14–2.09; ORGG=2.51, 95%CI 1.59-3.94, Ptrend=0.00002), C1RL rs12227050 (ORAG/GG=2.85, 95%CI 1.71–4.74, Ptrend=0.0001), and TYMS rs2342700 (ORCG=1.56, 95%CI 1.17–2.09; ORGG=2.18, 95%CI 1.30–3.64, Ptrend=0.0002) were associated with significantly increased risk of cervical cancer (Table 2). This evidence concerns the gene TELO2 and cervical cancer.